CClassifation of CannabisPublic classificationby Justin Strekal, NORML Political Director
October 16, 2018
Comments
The US Food and Drug Administration is seeking public comments specific to whether changes ought to be recommended regarding the international classification of cannabis as a controlled substance. Members of the public have until October 31, 2018 to submit their comments to the FDA for consideration.
The FDA says that the comments “will be considered in preparing a response from the United States to the World Health Organization regarding the abuse liability and diversion” of marijuana and certain other substances.
In April, in response to a similar FDA request, NORML collected and hand-delivered over 10,000 comments to the agency calling on it to recommend a lifting of international restrictions criminalizing the plant. In total, comments from NORML members totaled over 60% of the public comments submitted nationwide.
Click here to submit a public comment NOW
In NORML’s latest comments to the FDA, it opined that “cannabis be removed from the international drug conventions so that nations that wish to do so may further expand their regulations governing cannabis’ use, possession, production, and dispensing for either recreational or medical use.”
Let’s continue to dominate the debate. Click here to submit your own public comment now.
Then take the next step:
Share our Action Alert on Twitter
Share our Action Alert on Facebook
Posted in : ACTIVISM, Advocacy, Citizen Lobbyists, GOVERNMENT, Policy
Add Your Comment
Do your part to
help legalize marijuana! (how?)
Act!
Donate
Lawyers
Shop
NORML Newsletter
FDA Seeks Public Comments Regarding International Classification Of Cannabis
October 17, 2018
CClassifation of CannabisPublic classificationby Justin Strekal, NORML Political Director
October 16, 2018
Comments
The US Food and Drug Administration is seeking public comments specific to whether changes ought to be recommended regarding the international classification of cannabis as a controlled substance. Members of the public have until October 31, 2018 to submit their comments to the FDA for consideration.
The FDA says that the comments “will be considered in preparing a response from the United States to the World Health Organization regarding the abuse liability and diversion” of marijuana and certain other substances.
In April, in response to a similar FDA request, NORML collected and hand-delivered over 10,000 comments to the agency calling on it to recommend a lifting of international restrictions criminalizing the plant. In total, comments from NORML members totaled over 60% of the public comments submitted nationwide.
Click here to submit a public comment NOW
In NORML’s latest comments to the FDA, it opined that “cannabis be removed from the international drug conventions so that nations that wish to do so may further expand their regulations governing cannabis’ use, possession, production, and dispensing for either recreational or medical use.”
Let’s continue to dominate the debate. Click here to submit your own public comment now.
Then take the next step:
Share our Action Alert on Twitter
Share our Action Alert on Facebook
Posted in : ACTIVISM, Advocacy, Citizen Lobbyists, GOVERNMENT, Policy
Add Your Comment
Do your part to
help legalize marijuana! (how?)
Act!
Donate
Lawyers
Shop
NORML Newsletter
Search
RECENT PRESS RELEASES
The 29 best Amazon Black Friday tech deals our experts found
SWI Editorial StaffNovember 24, 2024|
Amazon workers in 20 countries to protest or strike on Black Friday
SWI Editorial StaffNovember 24, 2024|
Good, bad or ugly? What Elon Musk’s rise mean for the future of Nasa
SWI Editorial StaffNovember 24, 2024|
Wall Street Giant Engages Tether on Pivotal Bitcoin Lending Plan
SWI Editorial StaffNovember 24, 2024|
U.N. plastic pollution talks in Busan seek last-chance deal to curb waste
SWI Editorial StaffNovember 24, 2024|
Country diary: An area the size of York opened up to nature
SWI Editorial StaffNovember 24, 2024|
Related Post
Unlock Your Trading Potential
StockWatchIndex Trading Insights – A Six-Part Series of SWI White Papers
Infused beverages lead Election Day marijuana product sales spike
Nvidia Stock Is a Top Pick for November, According to 1 Wall Street Analyst